eBay Inc. (NASDAQ: EBAY) soared 1.97%, to close at $31.64 and its overall traded volume was 12.50M shares during the last session the stock had average daily volume of 10.56M shares. EBAY shares were trading within the range of $31.08-$31.77 while its opening price was $31.08. The stock has a 52 week low of $26.86 and 52 week high of $35.35. EBAY’s market capitalization is $40.85B and it has 1.29B outstanding shares.
eBay Inc. (eBay) bring together buyers and sellers every day on a local, national and international basis through a range of Websites. It provides online marketplaces for the sale of goods and services, as well as other online commerce, or ecommerce, platforms and online payment solutions to a diverse community of individuals and businesses. It operates in two business segments: marketplaces and payments. eBay generates two types of net revenues: net transaction revenues, marketing services and other revenues. Its net transaction revenues are derived from listing fees and final value fees, which are fees payable on transactions completed on its marketplaces trading platforms, and fees paid by merchants for payment processing services. In December 2010, it acquired Critical Path Software. In June 2011, it acquired GSI Commerce, Inc. In August 2011, the Company acquired Zong. In August 2011, the Company acquired Magento, Inc. In November 2011, the Company acquired http://hunch. com.
Endocyte, Inc. (NASDAQ: ECYT) surged 12.47%, to close at $11.00 and its overall traded volume was 93,813.00 shares during the last session the stock had average daily volume of 206,082.00 shares. ECYT opened at $9.84 and is trading within the range of $9.84-$11.11. The 52-week range of the stock is $6.15-$14.80. The market capitalization of the company stands at $393.12M and it has 35.74M outstanding shares. Endocyte, Inc. (Endocyte) is a biopharmaceutical company. The Company is engaged in developing therapies for the treatment of cancer and inflammatory diseases. Endocyte uses its technology to create small molecule drug conjugates (SMDCs), and companion imaging diagnostics. Its SMDCs target receptors that are over-expressed on diseased cells, primarily to healthy cells. The Company’s SMDCs consists of three modules: a targeting ligand, a linker and a drug payload. The foundation of its technology is its small molecule targeting ligands, which bind to over-expressed receptors on target cells, while avoiding healthy cells. It is developing a number of different targeting ligands for a range of cancers and inflammatory diseases. Its linker system attaches the targeting ligand to the drug payload. The drug payload is the biologically active component of its SMDCs. Endocyte’s core SMDC, EC145, targets the folate receptor.
Education Management Corp (NASDAQ: EDMC) percentage change surged 0.91%, to close at $23.23 and its overall traded volume was 138,722.00 shares during the last session the stock had average daily volume of 150,098.00 shares. EDMC opened at $22.93 and is trading within the range of $22.84-$23.52. The 52-week range of the stock is $13.45-$28.61. EDMC’s market capitalization is $2.96B and it has 127.39M outstanding shares. Education Management Corporation (EDMC) is a provider of post-secondary education in North America, with approximately 158,300 enrolled students as of October 2010. The Company offers academic programs to its students through campus-based and online instruction, or through a combination of both. The Company’s educational institutions offer students undergraduate and graduate degrees, including doctoral degrees, and certain specialized non-degree diplomas in a range of disciplines. These disciplines include media arts, health sciences, design, psychology and behavioral sciences, culinary, business, fashion, legal, education and information technology. Each of the Company’s schools located in the United States is licensed or permitted to offer post-secondary programs in the state in which it is located, accredited by a national or regional accreditation agency and certified by the United States Department of Education.
Electro Rent Corporation (NASDAQ: ELRC) soared 6.01%, to close at $16.77 and its overall traded volume was 85,585.00 shares during the last session with the total traded volume of 45,237.00 shares. ELRC opened at $15.89 and is trading within the range of $15.71-$16.95. The 52-week range of the stock is $12.64-$17.98. ELRC’s market capitalization is $402.15M and it has 23.98M outstanding shares. Electro Rent Corporation is engaged in the rental, lease and sale of new and used electronic test and measurement (T&M) equipment. The Company purchases the equipment from manufacturers, such as Agilent Technologies, Inc. and Tektronix primarily for use by its customers in the aerospace, defense, telecommunications, electronics, industrial and semiconductor industries. The Company maintains an equipment portfolio composed primarily of test and measurement equipment and personal computer-related data products (DP) equipment purchased from leading manufacturers. The Company’s ATP agreement with Agilent Technologies, Inc., effective December 1, 2009, gave the Company rights to sell Agilent’s T&M equipment to small to medium size customers in the United States and Canada. On March 31, 2010, the Company completed the acquisition of certain assets and select post-closing liabilities of Telogy, LLC. In August 2011, the Company acquired Equipment Management Technology, Inc.
Energy Recovery, Inc. (NASDAQ: ERII) percentage change surged 13.10%, to close at $2.85 and its overall traded volume was 180,383.00 shares during the last session against its average volume of 222,019.00. ERII opened at $2.54 and is trading within the range of $2.54-$2.91. The stock has a 52-week range of $2.09-$4.36. At current market price, the market capitalization of the company stands at $150.04M and it has 52.64M outstanding shares. Energy Recovery, Inc. develops, manufactures and sells energy recovery devices and pumps, and related parts and services primarily for use in seawater desalination. The Company’s products are sold under the trademarks AquaBold, AquaSpire, ERI, PX, Pressure Exchanger, PX Pressure Exchanger, PEI, Pump Engineering and Quadribaric. The Company develops and sells two lines of energy recovery devices: PX Pressure Exchanger devices and turbochargers. Each line includes a range of models and sizes to address the breadth of required process flow rates, plant designs and sizes. The Company has manufacturing facilities in San Leandro, California where its PX devices are made, assembled and tested, and in New Boston, Michigan where its turbochargers and pumps are manufactured and tested. During the year ended December 31, 2010, the Company integrated the operations of its new subsidiary, Pump Engineering, Inc. (PEI), and ERI sales operations.
